NEW YORK (GenomeWeb) – Microsaic Systems and Plexus today announced an agreement for the commercial manufacturing of Microsaic's 4000MiD miniature mass spectrometry system.
The instrument was launched in March 2013 and Plexus was chosen for its expertise with complex sub-assemblies and its ability to provide engineering solutions to support current and future product developments. Microsaic also sought to keep production close to its own facility in Surrey, UK.
Microsaic Chief Executive Colin Jump said in a statement that Plexus is an "excellent strategic fit" for his company, and through the agreement, "we gain the ability to optimize and scale our manufacturing to meet the increasing demand for our product now and in the future."